Sublingual Immunization with M2-Based Vaccine Induces Broad Protective Immunity against Influenza

• Byoung-Shik Shim,

  Affiliations Laboratory Science Division, International Vaccine Institute, Seoul, Republic of Korea, Department of Agricultural Biotechnology, Research Institute for Agriculture and Life Sciences, Center for Agricultural Biomaterials, Seoul National University, Seoul, Republic of Korea

  ⨯
• Young Ki Choi,

  Affiliation College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju, Republic of Korea

  ⨯
• Cheol-Heui Yun,

  Affiliation Department of Agricultural Biotechnology, Research Institute for Agriculture and Life Sciences, Center for Agricultural Biomaterials, Seoul National University, Seoul, Republic of Korea

  ⨯
• Eu-Gene Lee,

  Affiliation Laboratory Science Division, International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• Yoon Seong Jeon,

  Affiliation Laboratory Science Division, International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• Sung-Moo Park,

  Affiliation Laboratory Science Division, International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• In Su Cheon,

  Affiliations Laboratory Science Division, International Vaccine Institute, Seoul, Republic of Korea, Department of Agricultural Biotechnology, Research Institute for Agriculture and Life Sciences, Center for Agricultural Biomaterials, Seoul National University, Seoul, Republic of Korea

  ⨯
• Dong-Hyun Joo,

  Affiliation Laboratory Science Division, International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• Chung Hwan Cho,

  Affiliations Laboratory Science Division, International Vaccine Institute, Seoul, Republic of Korea, Department of Agricultural Biotechnology, Research Institute for Agriculture and Life Sciences, Center for Agricultural Biomaterials, Seoul National University, Seoul, Republic of Korea

  ⨯
• Min-Suk Song,

  Affiliation College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju, Republic of Korea

  ⨯
• Sang-Uk Seo,

  Affiliation Laboratory Science Division, International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• Young-Ho Byun,

  Affiliation Department of Biotechnology, College of Engineering, Yonsei University, Seoul, Republic of Korea

  ⨯
• Hae-Jung Park,

  Affiliation Laboratory Science Division, International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• Haryoung Poo,

  Affiliation Korean Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea

  ⨯
• Baik Lin Seong,

  Affiliation Department of Biotechnology, College of Engineering, Yonsei University, Seoul, Republic of Korea

  ⨯
• Jae Ouk Kim,

  Affiliation Laboratory Science Division, International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• Huan Huu Nguyen,

  Affiliation Laboratory Science Division, International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• Konrad Stadler,

  Affiliation Laboratory Science Division, International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• Dong Wook Kim,

  Affiliation Department of Pharmacy, College of Pharmacy, Hanyang University, Kyeonggi-do, Republic of Korea

  ⨯
• Kee-Jong Hong,

  Affiliation Division of Influenza Viruses, Korea National Institute of Health, Osong, Republic of Korea

  ⨯
• Cecil Czerkinsky,

  Affiliation Laboratory Science Division, International Vaccine Institute, Seoul, Republic of Korea

  ⨯
•  [ ... ],
• Man Ki Song

  * E-mail: mksong@ivi.int

  Affiliation Laboratory Science Division, International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• [ view all ]
• [ view less ]